Skip to content

Effectiveness of the Kinesiotaping in the Treatment of Chronic Lateral Epicondylitis

Effectiveness of the Kinesiotaping in the Treatment of Chronic Lateral Epicondylitis: a Randomized, Sham-controlled, Single-blind Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06611709
Enrollment
42
Registered
2024-09-25
Start date
2024-02-01
Completion date
2024-09-01
Last updated
2024-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral Epicondylitis (tennis Elbow), Pain

Keywords

kinesiotaping, lateral epicondylitis, pain, exercises

Brief summary

Lateral epicondylitis significantly impacts daily activities and productivity at work, making it a condition of substantial clinical and socioeconomic importance.Despite its high prevalence, clinical significance, and impact on daily life, the optimal management of LE remains a topic of ongoing debate. This study aims to investigate the efficacy of kinesiotaping (KT) on pain intensity, functional status, and quality of life in patients with chronic lateral epicondylitis (LE). The study was conducted in the outpatient clinic for level 3 physical medicine and rehabilitation. Patients were randomized into two groups: the real kinesiotaping + home exercise group and the sham taping + home exercise group (randomized by a medical secretary outside the study). A set of widely accepted, literature-consistent primer and seconder outcomes were statistically compared to determine whether one treatment was superior to the other.

Detailed description

Between February 1, 2024, and August 31, 2024, a total of 42 patients (17 females, 25 males) with chronic LE were included. Patients were randomized into either the KT or sham-controlled group. Patients were blinded to which group they were assigned to. The taping was performed by the same physician, who was trained and experienced in kinesiotaping. Kinesiotaping and sham-taping were applied six times over three weeks. Both groups received recommendations for activity modification and a home-based stretching and strengthening exercise program. The exercise program was designed by an author who has a national book chapter on exercise for the treatment of lateral epicondylitis, taking into account patient specificity and adherence, and in accordance with the literaturExercise adherence was monitored through weekly outpatient controls (while taping) and by phone check-ins two weeks after the taping was completed. Outcome measures were visual analog scale (VAS) pain score, Patient-Rated Forearm Evaluation Questionnaire (PRFEQ), grip strength, Disabilities of Arm, Shoulder, and Hand (DASH), quality of life in Short Form-36 (SF-36), and The Roles and Maudsley patient satisfaction score. The subjects were assessed before treatment, at the end of treatment (week three), and four weeks after the end of treatment (week seven).The assessment parameters were also conducted by the same researcher to ensure consistency.

Interventions

DEVICEsham taping (non-elastic medical cloth tape)

sham taping

DEVICEKinesiotaping: A standard 5-cm wide KinesioⓇ Tex Gold

A standard 5-cm wide KinesioⓇ Tex Gold

OTHERexercises

home-based exercises

Sponsors

Konya Beyhekim Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Kinesiotaping vs sham-taping

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 to 65 years * A pain severity of 4 or higher on the visual analog scale (VAS) during daily activities * A history of lateral epicondylitis symptoms lasting at least three months

Exclusion criteria

* Communication difficulties * Significant psychiatric disorders * A history of trauma within the past six months * Neuromuscular conditions * Abnormalities of the upper limb * Prior upper limb surgery * A history of rheumatic diseases * Cervical disc pathology, polyneuropathy, or hand disorders (such as carpal or cubital tunnel syndrome, de Quervain tenosynovitis, osteoarthritis) * Receipt of any treatment for lateral epicondylitis (e.g., local injections, physical therapy, splints) within the last six month

Design outcomes

Primary

MeasureTime frameDescription
Patient-Rated Tennis Elbow Evaluation Questionnaire (PRTEE)baseline, week 3, and week 70 (best) to 100 (worst)
VAS pain (0-10)baseline, week 3, and week 70 no pain; 10 unbearable/max. pain.

Secondary

MeasureTime frameDescription
The Disabilities of the Arm, Shoulder, and Hand (DASH)baseline, week 3, and week 70 (best condition) to 100 (worst condition)
grip strengthbaseline, week 3, and week 7using a Jamar® dynamometer (in kilograms)
The Short Form-36 (SF-36) quality of life indexbaseline, week 3, and week 70, indicating the worst health status, to 100, representing the best possible health
Patient satisfaction/benefit scale (The Roles and Maudsley score)baseline, week 3, and week 7The Roles and Maudsley score was utilized to evaluate pain and activity limitations in the assessment of treatment efficacy, categorized into four levels: 1 point indicating excellent, 2 points indicating good, 3 points indicating fair, and 4 points indicating poor.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026